SBIR/STTR Research Award
Novel Antimicrobial Agents Targeting Drug Resistant Bacterial Biofilms
Award amount
$738,292Program and phase
STTR · Phase IIAward year
2012Award details
- Awarding agency
- Department of Defense
- Branch
- Army
- Recipient company
- Enantigen Therapeutics
- Proposal award date
- 2011-12-16
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- 2009.A
- Topic code
- A09A-T004
Research abstract
This project builds on patterns derived from natural antimicrobial peptide sequences to develop novel compounds with better systemic activity, lower cytotoxicity and broader spectrum activity against multidrug resistant (MDR) pathogens. In Phase I and the
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Biomimetics for treating biofilm-embedded infections
- Biomimetics for treating biofilm-embedded infections
- Novel Antimicrobial Agents Targeting Drug Resistant Bacterial Biofilms
- Innovative technologies to effectively treat multi-drug resistant and/or biofilm-embedded bacteria